Dr. Robert McLean, IBC Chair and Professor, Biology

Dr. Maha Dharmasiri, Assistant Professor
Mr. David erb, Non-institutional Member
Dr. Dittmar Hahn, Associate Professor, Biology
Mr. Roger Hull, R.N., Non-institutional Member
Dr. Kevin (Lysle) Lewis, Associate Professor, Chemistry & Biochemistry
Mr. Rodney Rohde, Associate Professor, Clinical Laboratory Science
 

Ex Officio: Dr. Michael Blanda, Assistant Vice President, Research and Federal Relations
 

Function:

Institutional Biosafety Committee (IBCs) were established under the NIH Guidelines for Research Involving Recombinant DNA Molecules to provide local review and oversight of nearly all forms of research utilizing recombinant DNA. Over time, many institutions have chosen to assign their IBCs the responsibility of reviewing a variety of experimentation that involves biological materials (e.g., infectious agents) and other potentially hazardous agents (e.g., carcinogens).